Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2.133 INR | +3,26% | +14,12% | +12,40% |
25/04 | GlaxoSmithKline klaagt Pfizer en BioNTech aan voor Covid-19 vaccintechnologie | RE |
29/02 | Cynata Therapeutics benoemt Chief Business Officer; Aandelen kelderen 14% | MT |
Omzet 2024 * | 33,65 mld. 404 mln. 377 mln. | Omzet 2025 * | 36,49 mld. 438 mln. 409 mln. | Marktkapitalisatie | 361 mld. 4,33 mld. 4,05 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 6,06 mld. 72,72 mln. 67,98 mln. | Nettowinst (verlies) 2025 * | 7,68 mld. 92,09 mln. 86,09 mln. | EV/omzet 2024 * | 10,7 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 9,9 x |
K/w-verhouding 2024 * |
53,1
x | K/w-verhouding 2025 * |
47,1
x | Werknemers | 3.680 |
Dividendrendement 2024 * |
1,42% | Dividendrendement 2025 * |
1,48% | Vrij verhandelbaar | 24,42% |
1 dag | +3,26% | ||
1 week | +14,12% | ||
Lopende maand | +9,76% | ||
1 maand | +10,82% | ||
3 maanden | -2,23% | ||
6 maanden | +47,99% | ||
Lopend jaar | +12,40% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 54 | 01-12-22 |
Juby Chandy
DFI | Director of Finance/CFO | - | 01-04-22 |
Simrat Sohal
CMP | Compliance Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 70 | 01-04-19 |
Manu Anand
BRD | Director/Board Member | 64 | 16-05-22 |
Director/Board Member | 74 | 30-03-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 4 M€ | -4,41% | - | |
0.01% | 117 M€ | +1,11% | - | |
0.00% | 31 M€ | +3,50% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 2.133 | +3,26% | 6 612 |
25-04-24 | 2.065 | -0,69% | 14 837 |
24-04-24 | 2.080 | +7,06% | 20 430 |
23-04-24 | 1.943 | -0,28% | 3 115 |
22-04-24 | 1.948 | +4,24% | 5 393 |
uitgestelde koers Bombay S.E., 26 april 2024 om 12:19 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,40% | 4,2 mld. | |
+25,83% | 653 mld. | |
+27,00% | 556 mld. | |
-6,76% | 354 mld. | |
+20,34% | 331 mld. | |
+3,00% | 296 mld. | |
+13,09% | 233 mld. | |
+5,46% | 201 mld. | |
-9,61% | 193 mld. | |
-6,26% | 144 mld. |